Krish Ramadurai


Harmonix Fund

Krish Ramadurai is a Partner at Harmonix Fund and leads the firm’s technical due diligence, investment sourcing, and portfolio operational support across their healthcare, life sciences, and deep technology practices. At Harmonix, he manages a top-decile performing portfolio of 40+ companies with an enterprise value of over $7 Billion with numerous major scientific breakthroughs, including the world’s first AI-designed drug to enter clinical trials to the launch of the first commercial rideshare satellite into space. He is a multi-published author, advisor, lecturer, and former researcher at Harvard & MIT, who has published three internationally released books on applied engineering and medicine. He is a board observer for Sorcero and xCures and a venture advisor for Nucleate and the National Venture Capital Association.

Stay up to date

Subscribe to our free email updates.
You'll get about two emails per month. We'll never share your address.